Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies

Human Immunology

Volumn 73, Issue 3, 2012, Pages 267-277

  Duquesnoy, Rene J ^a   Marrari, Marilyn ^a   Mulder, Arend ^b   Claas, Frans H J ^b   Mostecki, Justin ^c   Balazs, Ivan ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Gen Probe Transplant Diagnostics   (United States)

Author keywords

Antibody; Eplet; HLA epitope; HLAMatchmaker; Immunogenicity; Nonself self paradigm of epitope

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; MONOCLONAL ANTIBODY;

ALLELE; ANTIBODY PRODUCING CELL; ANTIGEN BINDING; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGENICITY; PREGNANCY; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ALGORITHMS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; AUTOANTIGENS; COMPUTATIONAL BIOLOGY; CRYSTALLIZATION; EPITOPES, B-LYMPHOCYTE; FEMALE; HLA ANTIGENS; HUMANS; HYBRIDOMAS; IMMUNIZATION; MODELS, CHEMICAL; PREGNANCY; PROTEIN BINDING; PROTEIN CONFORMATION; SOFTWARE;

EID: 84857108057     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.11.011     Document Type: Article

References (45)

1. Kabat E.A., Wu T.T., Bilofsky H. Unusual distribution of amino acids in complementarity-determining (hypervarible) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites. J Biol Chem 1977, 252:6609-6617.
2. Kabat E.A. The structural basis of antibody complementarity. Adv Protein Chem 1978, 32:1-75.
3. Wu T.T., Johnson G., Kabat E.A. Length distribution of CDRH3 in antibodies. Proteins 1993, 16:1-7.
4. Shirai H., Kidera A., Nakamura H. H3-rules: identification of CDR-H3 structures in antibodies. FEBS Lett 1999, 455:188-197.
5. MacCallum R.M., Martin A.C.R., Thornton J.M. Antibody-antigen interactions: contact analysis and binding site topography. J Mol Biol 1996, 262:732-745.
6. Davies D.R., Padlan E.A., Sheriff S. Antibody-antigen complexes. Annu Rev Biochem 1990, 59:439-473.
7. Padlan E.A. Anatomy of the antibody molecule. Mol Immunol 1994, 31:169-217.
8. Getzoff E.D., Tainer J.A., Lerner R.A., Geysen H.M. The chemistry and mechanism of antibody binding to protein antigens. Adv Immunol 1988, 43:1-98.
9. Novotny J. Protein antigenicity: a thermodynamic approach. Mol Immunol 1991, 28:201-208.
10. Laune D., Molina F., Ferrieres G., Mani J.-C., Cohen P., Simon D., et al. Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins. J Biol Chem 1997, 272:30937-30944.
11. Bogan A.A., Thorn K.S. Anatomy of hot spots in protein interfaces. J Mol Biol 1998, 280:1-9.
12. Van Regenmortel M.H. Reductionism and the search for structure-function relationships in antibody molecules. J Mol Recognit 2002, 15:240-247.
13. Duquesnoy R.J. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006, 67:847-862.
14. Duquesnoy R.J. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. Curr Opin Immunol 2008, 20:594-601.
15. Duquesnoy R.J., Marrari M. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies. Curr Opin Organ Transplant 2009, 14:403-409.
16. Duquesnoy R.J., Mulder A., Askar M., Fernandez-Vina M., Claas F.H.J. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum Immunol 2005, 66:749-761.
17. Duquesnoy R.J., Marrari M. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens. Tissue Antigens 2009, 74:117-133.
18. Marrari M., Mostecki J., Mulder A., Claas F., Balazs I., Duquesnoy R.J. Human monoclonal antibody reactivity with human leukocyte antigen class I epitopes defined by pairs of mismatched eplets and self eplets. Transplantation 2010, 90:1468-1472.
19. Duquesnoy R. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity. Int J Immunogenet 2011, in Press.
20. Tonegawa S. Somatic generation of antibody diversity. Nature 1983, 302:575-581.
21. Kim S., Davis M., Sinn E., Patten P., Hood L. Antibody diversity: somatic hypermutation of rearranged VH genes. Cell 1981, 27:573-581.
22. Nossal G.J., Pike B.L. Clonal anergy: persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen. Proc Natl Acad Sci U S A 1980, 77:1602-1606.
23. Hayakawa K., Asano M., Shinton S.A., Gui M., Allman D., Stewart C.L., et al. Positive selection of natural autoreactive B cells. Science 1999, 285:113-116.
24. Pillai S., Cariappa A., Moran S.T. Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol Rev 2004, 197:206-218.
25. Morris S.C., Moroldo M., Giannini E.H., Orekhova T., Finkelman F.D. In vivo survival of autoreactive B cells: characterization of long-lived B cells. J Immunol 2000, 164:3035-3046.
26. Heltemes L.M., Manser T. Level of B cell antigen receptor surface expression influences both positive and negative selection of B cells during primary development. J Immunol 2002, 169:1283-1292.
27. Gay D., Saunders T., Camper S., Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 1993, 177:999-1006.
28. Tiegs S.L., Russell D.M., Nemazee D. Receptor editing in self-reactive bone marrow B cells. J Exp Med 1993, 177:1009-1020.
29. Pelanda R., Torres R.M. Receptor editing for better or for worse. Curr Opin Immunol 2006, 18:184-190.
30. Marrari M., Conca R., Praticò-Barbato L., Amoroso A., Duquesnoy R. Brief report: why did two patients who type for HLA-B13 have antibodies that react with all Bw4 antigens except HLA-B13?. Transpl Immunol 2011, 25:217-220.
31. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996, 381:751-758.
32. Mulder A., Kardol M., Blom J., Jolley W.B., Melief C.J., Bruning H. A human monoclonal antibody, produced following in vitro immunization, recognizing an epitope shared by HLA-A2 subtypes and HLA-A28. Tissue Antigens 1993, 42:27-34.
33. Mulder A, Kardol M, Niterink J, Parlevliet J, Marrari M, Tanke J, et al. Successful strategy for the large scale development of HLA-specific human monoclonal antibodies. Presented at the 12th International Histocompatibility Workshop, Paris; 1996.
34. Mulder A., Kardol M., Regan J., Buelow R., Claas F. Reactivity of twenty-two cytotoxic human monoclonal HLA antibodies towards soluble HLA class I in an enzyme-linked immunosorbent assay (PRA-STAT). Hum Immunol 1997, 56:106-113.
35. Maiers M., Gragert L., Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol 2007, 68:779-788.
36. Hogue C.W. Cn3D: a new generation of three-dimensional molecular structure viewer. Trends Biochem Sci 1997, 22:314-316.
37. McCutcheon J.A., Lutz C.T. Mutagenesis around residue 176 on HLA-B*0702 characterizes multiple distinct epitopes for anti-HLA antibodies. Hum Immunol 1992, 35:125-131.
38. McCutcheon J.A., Smith K.D., Valenzuela A., Aalbers K., Lutz C.T. HLA-B*0702 antibody epitopes are affected indirectly by distant antigen residues. Hum Immunol 1993, 36:69-75.
39. Hülsmeyer M., Chames P., Hillig R.C., Stanfield R.L., Held G., Coulie P.G., et al. A Major histocompatibility complex-peptide-restricted antibody and T cell receptor molecules recognize their target by distinct binding modes; crystal structure of human leukocyte antigen (HLA)-A1 -MAGE-A1 complex with Fab-Hyb3. J Biol Chem 2005, 280:2972-2980.
40. Sherman L.A., Chattopadhyay S., Biggs J.A., Dick R.F., Bluestone J.A. Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides. Proc Natl Acad Sci U S A 1993, 90:6949-6951.
41. Wang J., Yu D.T., Fukazawa T., Kellner J., Wen J., Cheng X.K., et al. A monoclonal antibody that recognizes HLA-B27 in the context of peptides. J Immunol 1994, 152:1197-1205.
42. Noun G., Reboul M., Abastado J.P., Jaulin C., Kourilsky P., Pla M. Alloreactive monoclonal antibodies select Kd molecules with different peptide profiles. J Immunol 1996, 157:2455-2461.
43. Mulder M., Eijsink C., Kester M.G.D., Franke M.E.I., Kardol M.J., Heemskerk M.H.M., et al. Impact of peptides on the recognition of HLA Class I molecules by human HLA antibodies. J Immunol 2005, 175:5950-5957.
44. Duquesnoy R. Humoral alloimmunity in transplantation: relevance of HLA epitope antigenicity and immunogenicity. Frontiers in Transplantation and Alloimmunity 2011, 2:59.
45. Roberts V., Getzoff E., Tainer J. 1993. Structural basis of antigenic cross-reactivity. Structure of antigens 1993, 31-53. CRC Press, Boca Raton. M. Van Regenmortel (Ed.).